secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2025-06-09T23:59:59+00:00
Accession:  0001213900-25-052413
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive shareholders elect four directors and approve reverse stock split at 2025 annual meeting
--------------------------------------------------------------------------------

- All four director nominees elected: Dr. Aggarwal, Dr. Gupta, Dr. Laumas, Dr. Kenkare-Mitra.
- Ratification of Grassi & Co. as independent auditor approved (87.8M for, 531.6K against).
- Reverse stock split proposal approved (78.1M for, 9.6M against, 771.4K abstain).
- 69.7% of total voting power was represented at the meeting (88.4M of 126.9M votes).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390025052413/0001213900-25-052413-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390025052413/ea0245071-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-052413

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer